RxSight, Inc.RXSTNASDAQ

Revenue (LTM)

$134M

-3.9% YoY

Net Income (LTM)

$-39M

-41.8% YoY

Free Cash Flow

$-19M

Revenue CAGR (5Y)

+56.2%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	23	49↑116.9%	89↑81.8%	140↑57.1%	134↓3.9%
Gross Profit	5	21↑372.2%	54↑152.1%	99↑84.0%	103↑4.1%
Operating Income	-53	-63↓19.9%	-50↑20.9%	-37↑26.4%	-48↓30.7%
Net Income	-49	-67↓37.1%	-49↑27.2%	-27↑43.5%	-39↓41.8%
EBITDA	-41	-58↓40.9%	-41↑29.0%	-24↑42.1%	-40↓66.8%
EPS Diluted	-1.78	-2.41↓35.4%	-1.41↑41.5%	-0.71↑49.6%	-0.95↓33.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	24	12↓51.4%	10↓18.1%	17↑72.4%	20↑19.4%
Total Current Assets	176	135↓23.7%	168↑25.2%	294↑74.5%	287↓2.2%
Total Assets	193	150↓22.1%	183↑21.6%	319↑74.5%	312↓2.1%
Total Current Liabilities	11	17↑55.6%	21↑21.3%	26↑23.8%	26↑1.5%
Total Liabilities	54	60↑10.6%	22↓63.2%	37↑68.2%	36↓3.2%
Total Equity	138	90↓35.0%	160↑78.4%	281↑75.4%	276↓2.0%
Total Debt	45	45↑0.1%	3↓93.3%	12↑308.2%	11↓10.2%
Net Debt	21	33↑61.2%	-7↓120.1%	-4↑34.0%	-9↓102.0%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-45	-59↓31.6%	-42↑29.3%	-17↑59.3%	-16↑8.5%
Capital Expenditure	-2	-2↓23.4%	-5↓101.2%	-5↓13.0%	-4↑29.6%
Free Cash Flow	-47	-61↓31.3%	-46↑24.2%	-22↑51.8%	-19↑13.6%
Stock-Based Comp	8	11↑50.5%	16↑38.2%	25↑56.5%	0
Net Change in Cash	11	-13↓217.4%	-2↑82.6%	7↑421.8%	3↓54.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance